SC 13G Filing

Company

Vanda Pharmaceuticals Inc.

Filed

January 22, 2010

Accession Number

0001132413-10-000001

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →